Substantial variation in plasma lipid, lipoprotein, and apolipoprotein B levels was found in a sample of healthy white collar workers aged 23-59 years (144 women, 371 men) devoid of most clinically identifiable manifestations of cardiovascular disease or major biochemical anomalies and for whom data were gathered in Montreal, Canada, in 1987. The nature of this variability was examined for each gender by means of a stepwise linear regression analysis using indices of biologic variation and behavioral traits. In women, age, height, and weight together accounted for =10% and uric acid for another 7-10% of total cholesterol, low density lipoprotein (LDL) cholesterol, and apolipoprotein B level variation. In men, age alone accounted for 13-16% of the total variation in these traits while uric acid contributed only 3%. The additional contribution of behavioral traits was found to be at least double that associated with the indices of biologic variation for measures of very low density lipoprotein (VLDL) and high density lipoprotein (HDL) cholesterol in women and HDL cholesterol in men. After taking all of the above into account, genetic variation determined by the three common apo Ealleles explained an additional 6% of LDL cholesterol variation in women and 3.5% in men. These results emphasize the range of variability in lipid, lipoprotein, and apolipoprotein values in healthy individuals as well as important gender differences in the contribution of biologic, behavioral, and genetic factors in this variability. Am J Epidemiol 1999;150:1229-37. cardiovascular diseases; health status; men; risk factors; women This study was motivated by the need to expand our knowledge about the distribution of measures of cardiovascular health in asymptomatic individuals. Such information is essential for the proper evaluation of the role of these measures in the identification of healthy individuals at increased risk of disease. More specifically, we wanted to determine the extent to which interindividual variations in quantitative intermediate biologic and physiologic traits may be dependent on context defined by sex.
This study was motivated by the need to expand our knowledge about the distribution of measures of cardiovascular health in asymptomatic individuals. Such information is essential for the proper evaluation of the role of these measures in the identification of healthy individuals at increased risk of disease. More specifically, we wanted to determine the extent to which interindividual variations in quantitative intermediate biologic and physiologic traits may be dependent on context defined by sex.
Indeed, studies aimed at evaluating plasma lipid, lipoprotein, and apolipoprotein levels in populations have shown the existence of considerable variability, not only between populations (1), but also within them (2, 3) . When specific population groups have been studied, individuals have in general been unselected, such that various disease states and the use of con-comitant medications may have contributed to the observed intra-population interindividual variability. In order to minimize the contribution of these factors as possible sources of variation, we studied the variability in plasma lipid and lipoprotein traits in a sample of healthy individuals, free from clinical manifestations of cardiovascular disease, hypertension, diabetes mellitus, chronic disorders requiring medication, previously diagnosed thyroid, renal or liver dysfunction, or hyperlipidemia (4) . Interindividual variation in these traits in this selected sample makes possible an unbiased evaluation of the combined influences of age, anthropometric, and genetic variations as well as life-style. To this end, we quantified possible sources of this variation, including gender differences, with respect to five indices of biologic variation (age, height, weight, glucose, uric acid) and six behavioral traits (smoking, physical activity level, alcohol intake, diet, perceived stress, caffeine excess), as well as the genetic influence of the apo E polymorphism.
MATERIALS AND METHODS

Subjects and study criteria
The sample studied was drawn from white collar workers (women and men) employed by Hydro- Quebec, a major utility company in Montreal, Canada. The source of subjects was selected on the basis of the large number of workers available, the proximity of the company work place to our research center and the availability of medical records on all employees. We sought individuals who were between 20 and 59 years of age, had no history or clinical manifestations of metabolic disorders including hyperlipidemia, no clinical or electrocardiogram manifestations of cardiovascular disease, and no hypertension, either treated or untreated (defined at the time as a blood pressure of £150/90 mmHg on any single occasion). Exclusion criteria included known thyroid, liver, or kidney dysfunction, diabetes, gout, obesity, alcoholism, known hyperlipidemia, chronic disorders requiring medication, and current pregnancy. Further details in regard to the conduct of the study and the exclusion criteria have been presented previously (4) . In summary, through an initial screening of 3,028 available medical records, 2,008 individuals were identified as potential candidates for the study. A written invitation to participate was sent, in randomized order, to 1,492 persons, of whom 788 (52.8 percent) expressed their willingness to participate and 740 attended an interview. Our study was thus conducted in a sample that is representative of a population of inference that has no clinical signs of disease as defined by the above exclusion criteria.
Protocol
The protocol included a questionnaire and a brief clinical examination to confirm candidate eligibility (4) . Further causes for exclusion at this stage included a blood pressure reading £150 mmHg (systolic) or £90 mmHg (diastolic) or a body mass index (BMI) (weight (kg)/(height(m)
2 )of>30. A standardized interview was conducted by trained personnel to evaluate smoking habits, physical activity, sources of perceived stress, use of alcohol, and dietary habits. Individuals were questioned in detail with respect to each behavioral trait. Their answers were recorded and classified in a standardized manner (see below). Of the 740 individuals who came for interview, 626 subjects (409 men, 217 women) had a blood sample taken, the remaining 114 being excluded either on the basis of the study criteria (n = 100), or because they did not report for blood sampling (n = 14). There were 38 a posteriori exclusions due to missing or abnormal liver or renal function tests, to hyperuricemia (>475 (imol/liter) or hyperglycemia (>6.66 mmol/liter), chronic or acute use of medication, obesity (BMI >30) or prior enrollment of a first-degree relative, resulting in a final sample of 588 (205 women and 383 men) unrelated, healthy individuals.
Laboratory analyses
Blood samples were collected after a 12-14-hour fast into tubes containing 1.5 mg/mL disodium ethylenediamine tetra-acetic acid for lipid, lipoprotein, and apolipoprotein determinations and centrifuged in our laboratory within 2 hours of sampling. Routine serum biochemistry (sequential multichannel autoanalyzer (SMAC) and liver function tests) were analyzed at Hotel-Dieu Hospital, Montreal. Plasma lipoproteins were separated under standardized conditions by a combination of ultracentrifugation and heparin-manganese precipitation of the apolipoprotein B-containing lipoproteins in the d> 1.006 g/mL infranatant, according to the Lipid Research Clinics protocol (5) . High density lipoprotein subfraction 3 (HDL3) cholesterol levels were determined after precipitation of HDL subfraction 2 (HDL2) cholesterol with dextran sulfate, the difference between total HDL cholesterol and HDL3 cholesterol being taken to represent HDL2 cholesterol (6) . Plasma and lipoprotein cholesterol (7) and triglycerides (8) were measured enzymatically on an automated analyzer (Abbott Bichromatic Analyzer 100, Abbott Laboratories, Pasadena, CA, in routine use in our laboratory at the time of this study). Values reported in this article have been adjusted to correspond to our current methodology which is CDC standardized (Roche Cobas Mira S, Hoffmann-La Roche, Basel, Switzerland). Very low density lipoprotein (VLDL) apolipoprotein B and LDL apolipoprotein B were measured by electroimmunoassay (9), using a commercial serum (Behringwerke, Marburg, West Germany) and a frozen serum pool as secondary standards. The apo E phenotype was determined on VLDL apolipoproteins by isoelectric focusing (10) .
Statistical analyses
Data were analyzed using the Statistical Analysis System developed by the SAS Institute Inc. (11) . All statistical analyses were carried out separately for women and men. Separate regression equations were estimated for women and men, because the distributions of lipid traits and relations with most other traits are known to be sex-specific (12) (13) (14) (15) and the natural history of coronary heart disease is different in women and men (16) . Data from individuals whose values deviated by more than four standard deviations from their gender mean for any trait (three women, eight men) were removed from the study on the basis that these extreme values might be a consequence of unreported disease, laboratory errors, or a non-fasting state and should not be regarded as representative of a healthy sample. The remaining sample included 202 women (mean age 36.4 ± 7.0 years, range 23-56 years) and 375 men (mean age 38.6 ± 7.7 years, range Plasma LJpids and Lipoproteins in Health 1231 years). Of the 202 women, 57 were taking either oral contraceptives (n = 44) or hormonal replacement therapy (n = 13). These women are excluded for the purpose of this report because of the known influences of exogenous sex hormones on lipid levels which could mask the effect of the concomitant variables and behavioral traits which we wish to study. Further, the size of this group is too small to allow a separate analysis. Four other exclusions were also necessary due to missing values (glucose in one woman and information on the life-style questionnaire in three men). Finally, one man who presented with the rare apo E phenotype E5/3 was excluded. Log 10 transformed values of total and VLDL triglyceride were used to reduce skewness. The statistical significance of the difference between two group means was evaluated using Satterthwaite's approximation of the t test when intra-group variances were significantly different. The F statistic was used to test the hypothesis of equality of variances between groups. We denote differences that are statistically different at the 0.10,0.05, 0.01, and 0.001 level of probability.
Four linear regression models were considered. The first two models included concomitant variables: age, height, weight (model A) and age, height, weight, glucose, and uric acid (model A0-A fourth order polynomial of each of these indices of biologic variation fit to the data so as to explain the greatest amount of trait variation. In model A, the contribution of height was considered after adjustment for age and the contribution of weight was considered after adjustment for age and height. In model A', the contribution of glucose was considered after adjustment for age, height, and weight, and the contribution of uric acid was considered after adjustment for age, height, weight, and glucose. Next, we evaluated the contribution of cigarette smoking, alcohol intake, physical activity level, diet, caffeine intake, and stress to variation in six behavioral traits (BT). These were added as discrete classes to the regression model after fitting the indices of biologic variation (model BT|A'). Finally, the contribution of common variations in the apo E gene to trait variation was estimated (model E| A' |BT). The significance of the contribution of traits that are added to the regression model was tested using the F ratio = [SSR (complete model) -SSR (reduced model) / degrees of freedom associated with the difference] / MSE (complete model), where SSR and MSE are "sums of squares attributable to the regression relation" and "mean square error," respectively. The MSE for the most complete model (E | A' | BT) was used in each F test of the contribution of traits that are added to the regression model. We denote differences that are statistically different at the 0.10, 0.05, 0.01, and 0.001 levels of probability.
RESULTS
The sample consisted of >99 percent Caucasians with remaining individuals (two women and two men) being of Asian descent. The latter had unexceptional lipid levels and values of other measured variables. More men than women took part in this study, which is consistent with the institution's employee profile. Table 1 presents the means and variances for the indices of biologic variation and plasma lipid, lipoprotein, and apolipoprotein B levels as well as the ranges observed in women and men. Women were slightly, but significantly, younger than men. As expected, the means of all anthropometric and lipid traits were significantly lower in women than in men, with the exception of total HDL and HDL2 cholesterol, which were higher in women. The significant difference in total triglycerides between women and men was accounted for by VLDL triglycerides. All lipid and apolipoprotein B values showed a wide range of variation and, except for total HDL cholesterol and HDLj cholesterol, variances were significantly greater for men than for women (table 1). These gender differences further justify the separate analyses of the contribution of variation in indices of biologic, behavioral, and genetic traits to interindividual variation in lipid and lipoprotein levels presented below. Tables 2 and 3 summarize the percent of trait variation in women and men explained by the indices of biologic variation: age, height, weight, glucose, and uric acid all raised to the 4th order. Age influenced few traits in women, whereas it was the most important source of variation in lipid (except HDL cholesterol) and apolipoprotein B levels in men. Variation in weight after adjustment for age and height was the most important determinant of total HDL and HDL2 cholesterol variation in both women and men. The total percent contribution of age, height, and weight to the variability in total and in apolipoprotein B-containing lipoproteins (model A) was greater in men than in women. In women, percents of explained cholesterol variation and variation in measures of apolipoprotein B level became more similar to those observed in men only after inclusion of glucose and uric acid in the model (total percent model A'). Accordingly, in women, the contribution of glucose and uric acid in the second model (A') explained more variability than the reduced model (A) for total cholesterol, VLDL cholesterol, LDL cholesterol, total triglycerides, VLDL triglycerides, and LDL apolipoprotein B. The increase associated with adding glucose and uric acid was statistically significant at the 0.01 level of probability for LDL cholesterol and VLDL apolipoprotein B and at the 0.10 level of probability for total cholesterol and LDL apolipoprotein B. In men, indices of biologic variation in the A' model con- • When variances were significantly heterogeneous, Satterthwaite's approximation was used. t Apolipoprotein B in mg/dl. X NS, not statistically significant at 0.10 level of probability.
§ VLDL, very low density llpoprotein; LDL, low density lipoproteln; HDL, high density lipoprotein. t Model A = percent sum of squares regression associated with age, height, and weight, each to the fourth order. This total sum of squares is partitioned into a component attributable to age, height adjusted for age and weight adjusted for age and height; model A' = percent sum of squares regression associated with model A plus glucose after adjusting for variables in model A and uric acid, and after adjusting for variables in model A and glucose; significance of the contribution to variation: *p < 0.10; **p < 0.05; ***p < 0.01; ****p < 0.001; NS, not statistically significant at 0.10 level of probability.
t VLDL, very low density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein.
tributed significantly to triglyceride level variation. Despite the fact that different indices of biologic variation were significantly associated with each dependent trait in women and men, the percent of total variation (total percent model AO associated with all indices considered together was similar for women and men for every trait Furthermore, the relative sizes of the total variance of each trait in women and men remained unchanged after adjustment for variation in the indices (variances of adjusted traits not shown). t Model A = percent sum of squares regression associated with age, height, and weight, each to the fourth order. This total sum of squares is partitioned into a component attributable to age, height adjusted for age and weight adjusted for age and height; model A' = percent sum of squares regression associated with model A plus glucose after adjusting for variables in model A and uric acid after adjusting for variables in model A and glucose; significance of the contribution to variation: *p < 0.10; **p < 0.05; ***p < 0.01; ****p < 0.001; NS, not statistically significant at 0.10 level of probability.
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We next turned to evaluating the contribution to variation of six discrete measures of personal behavior: cigarette smoking, alcohol intake, physical activity, sources of perceived stress, diet, and caffeine excess. Before undertaking the regression analyses, we estimated the influence of smoking on lipid and lipoprotein levels and divided the sample into smokers and nonsmokers. Subjects who had never smoked or had not smoked cigarettes for at least 1 year (90 women, 251 men) were compared with the smokers (54 women, 120 men, 37.5 percent, and 32.3 percent of the sample, respectively), without distinction in regard to the number of cigarettes smoked. Comparison of group means revealed that smoking was associated in both sexes with a statistically significant (p < 0.05) increase in VLDL and LDL lipid and apolipoprotein B values and a decrease in HDL cholesterol. These differences were not associated with age or with height and weight (data not shown). For the regression analyses, four categories of smoking were created: nonsmokers, light (1-9 cigarettes per day), moderate (10-19 cigarettes), and heavy (>20 cigarettes) smokers.
A similar strategy was used to evaluate the influence of alcohol intake and physical activity level on lipid and lipoprotein trait variation. Alcohol intake was classified as follows: little or none (0-10 alcohol equivalents/week, one equivalent (eq.) corresponding to 10 g alcohol); moderate (11-21 eq./week); and large intake (>22 alcohol eq./week). Four levels of activity were defined based on a composite of information gathered concerning the type of work and the amount of exercise and sports activities reported. The first level, sedentary, included individuals who reported no physical activity apart from their office work, regular housekeeping activities, and limited walking. Persons who reported weekly planned exercise were grouped under light activity. The moderate activity level corresponded to sports or exercise three times per week. Finally, participation in a regular physical training program placed individuals in the intense activity level.
The other behavioral traits studied were as follows: stress (using a subjective perception of stress at work, at home, or in personal life: little, moderate, or heavy stress), caffeine excess (>4 cups coffee or tea/day) and diet (balanced vs. rich in carbohydrate or fat or both, as evaluated by a dietitian from the initial questionnaire) exerted only marginal effects in this sample. They are, however, included in the multiple regression model in an attempt to account for the greatest amount of variation.
The results of analyses of the six behavioral traits (BT) in the regression model presented in table 4 show that their inclusion made a significant contribution to lipids and measures of apolipoprotein B levels that had been adjusted for variation in age, height, weight, glucose, and uric acid in both women and men, particularly on variation in HDL cholesterol and triglyceride levels. The latter was especially evident for variation in triglycerides levels in women, for whom behavioral traits explained more variation than the indices of biologic variation. For the purpose of determining the sig- t A' model = percent sum of squares attributable to regression of a trait on 4th order polynomial of each Index of biologic variation: age, height, weight, glucose, and uric acid; BT I A' model = percent sum of squares attributable to regression of a trait on behavioral trait classes (smoking, alcohol intake, activity level, diet, stress, caffeine excess) after adjustment for traits in the A' model; total model = percent sum of squares attributable to indices of biologic variation and behavioral trait (BT) classes; significance of the contribution to variation of the A' model or of the BT I A 1 model or of the total model: *p < 0.10; **p < 0.05; ***p < 0.01; ****p < 0.001. $ VLDL, very low density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein.
nificance of the individual contribution of the behavioral traits, a stepwise regression analysis was conducted after adjustment for the biologic traits. In women, smoking was found to be by far the most significant predictor of variability. It was the first selection (p <, 0.05) for nine of the 11 variables considered. Smoking contributed from 29 percent (HDL3 cholesterol) to 77 percent (log triglycerides) of the variation explained by the six life-style factors. Although smoking was a significant predictor of variation in men (between 8 percent for LDL cholesterol and 44 percent for log triglycerides), alcohol intake, the activity level, and smoking were found to each explain approximately 25 percent of HDL cholesterol variability, while activity and smoking explained 48 and 40 percent, respectively, of log triglycerides. After adjustment for indices of biologic variation and measures of life-style, the variance of lipid traits and measures of apolipoprotein B levels remained significantly (p <> 0.05) larger in men than in women (variance of adjusted traits not shown).
An analysis of the association of variation in measures of lipid metabolism with variation in the gene coding for apo E is presented in table 5. Variation in apo E genotypes explained a significant fraction of variation in levels of LDL cholesterol (5.8 and 3.4 percent in women and men, respectively) and LDL apolipoprotein B (5.3 and 4.2 percent in women and men, respectively) after adjustment for variation in indices of biologic variation and behavioral traits in both women and men. In every case, the fraction explained was less than 6.0 percent of the total phenotypic variation.
Most of the variation in measures of lipid metabolism was not associated with measured variation in indices of biologic variation, behavioral traits, and apo E genotypes. The unexplained variation ranged from 55 percent for VLDL apolipoprotein B in women to 81 percent for HDL3 cholesterol in men. After adjustment for the variation explained by the complete regression model, the residual variance of lipid and apolipoprotein B traits remained significantly larger in men than in women (table 5). Despite the fact that different combinations of indices of biologic variation explain different fractions of trait variation in women and men, the relative size of the difference in trait variance between genders remained essentially the same after adjustment as it was before adjustment (see table 1 ).
DISCUSSION
The sample studied represents a group of women and men who were in good health (documented clinically and biochemically), not clinically obese, not taking medication, and with no known risk factors for coronary artery disease, other than smoking or a positive family history of cardiovascular disease. With these unique characteristics, this sample is important because knowledge about the distribution of measures of cardiovascular health in individuals without clinically defined symptoms is needed for the evaluation of the role of these measures in identifying those at risk of disease. Indeed, in the study of cardiovascular disease, one should be reminded that the traits that determine health are the same traits that determine disease (17) . t ApoE I A' I BT model = percent sum of squares attributable to apolipoprotein E after adjustment for indices of biologic variation and behavioral traits (BT); complete model = percent sum of squares attributable to all identified sources of variation in lipid traits. Significance of contribution to variation of the ApoE I A' IBT model or of the complete model: *p< 0.10; "p< 0.05; "*p<0.01; ****p< 0.001; NS, not statistically significant at 0.10 level of probability.
$ VLDL, very low density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein.
As stated above, two cardiovascular risk factors remained in this study: smoking and a positive family history of cardiovascular disease. They were not exclusion criteria because they do not define an individual's current health status but rather are predictors of future health. Smoking is an important socio-behavioral component of a free-living population and is highly prevalent in Quebec (18) . It was thus of interest to evaluate the impact of smoking on the lipid profiles of the study participants. Further, we did not exclude individuals with a positive family history of cardiovascular disease because family history, despite its overt simplicity, remains a poorly quantified variable, likely due to its inherent complexity. Models have yet to be developed that specifically combine the available information on the individual's measures of health with position in family, birth order, number of siblings, number in family with clinically defined disease, etc.
In this sample, we found lipid levels to be generally lower than those reported in studies which used less stringent selection criteria. Our healthy women and men had lower cholesterol levels (average difference: 0.2-0.3 mmol/liter) than participants of the LRC Prevalence Study (19) or the Canadians of the more recent Heart Health Surveys (20) . The observation of lower triglycerides levels (overall difference -24 percent to -40 percent) was particularly striking, emphasizing the potential importance of conditions excluded from our study, such as clinical obesity, diabetes, anti-hypertensive therapy, or moderate biochemical abnormalities, in the etiology of hypertriglyceridemia.
The average level and the variance of every lipid and lipoprotein trait, except HDL 3 cholesterol, were significantly different between women and men. The higher levels of VLDL and LDL traits and the lower levels of HDL cholesterol in men compared with women are consistent with expected sex-associated mean differences (19) . Our study documents that differences in trait variances between women and men persist after adjustment for variation in indices of biologic variation, behavioral traits, and the apo E gene (table 5) . This heterogeneity is consistent with the sex-specific natural history of coronary disease (16) . However, the possibility of a significant difference in interindividual trait variation between women and men is seldom taken into consideration when studying the sources of phenotypic variation in quantitative risk factors for coronary artery disease. The presence of heterogeneity of variance between the sexes brings into question the validity of inferences from studies that pool women and men to estimate the impact of age, anthropometric, behavioral, and genetic differences on trait variation. Estimates obtained from such pooled samples cannot be appropriate for either women or men (13) .
In spite of the careful selection of our study participants to be free of overt disease, there were important sex differences in the association of indices of biologic variation and behavioral trait classifications with trait variation. Although the total contribution of these to predicting variation in any particular lipid or lipoprotein trait was remarkably similar in women and men (total percent sum of squares, table 4), there were major differences in the relative contribution of particular predic- tors. Figure 1 summarizes the striking sex differences in the contribution of predictor variables to interindividual variation in LDL cholesterol. Age made the greatest contribution in men and uric acid made the greatest contribution in women, after adjustment for other indices of biologic variation. The behavioral traits predicted significant variation in most lipid traits (total cholesterol was an exception) in both women and men, despite some gender differences in their impact. Our results are in accordance with the proposition (17) that the relation between predictor variables and measures of lipid metabolism may be context dependent. Gender as an index of context in our study is also consistent with the findings of Reilly et al. (14) . These separate studies of women and men that reveal different relations between variations in causes and interindividual variation in lipid and lipoprotein traits strongly support the argument that recommendations for alterations in risk factor traits to modify risk of coronary artery disease must be sex-specific. Contextdependent associations imply different natural histories and different causations and hence the need for different approaches to detection, evaluation, and prevention of coronary disease in women and men.
A small but statistically significant impact of the apo E polymorphism on measures of LDL metabolism persisted after adjustment for variation in indices of biologic variation and behavioral traits (table 5 and figure  1 ). The stronger association observed in women is consistent with the findings of other studies (4, 21, 22) .
Our analyses further emphasize what many other studies of a wide range of sampling schemes have already established: that no single gene that has been studied thus far explains more than 6 percent of total phenotypic variance in the population at large for any of the measures of lipid metabolism considered here. Causations indexed by age and body size explain 4-8 times more variation than does variation in the gene coding for apo E. Although our study further documents (see also reference 23) that genetic information can improve the ability to predict after considering variation in traditional concomitants, the marginal effects of variations in any particular gene are expected to be small. Most genetic effects will be dependent on the context defined by sex, age, other genes, and current or past exposures to environmental influences that are not defined by the biology of the organism (14, 24) . Finally, as with other studies of quantitative variation in lipid and lipoprotein traits, the largest fraction (55 to 80 percent) of variation in lipid and lipoprotein traits among the healthy members of the sample considered here remains unexplained by the predictors considered.
The relations between interindividual variations in causes and variation in quantitative intermediate biologic and physiologic traits that link variation in causes with interindividual variations in onset, progression, and severity of coronary disease are complex and sexspecific (17, 25) . Most population-based studies seek to
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WT Glucose Women Men FIGURE 1. A graphic summary of the percent contribution of indices of biologic, behavioral, and genetic traits to the total sum of squares of low density lipoprotein (LDL) cholesterol variation in the samples of women and men white collar workers studied in Montreal, Canada. The contribution of each trait is conditional on adjustment for all preceding traits beginning with age, then height (HT) after adjustment for age, weight (WT) after adjustment for age and HT, glucose after adjustment for age, HT and WT, uric acid after adjustment for age, HT, WT, and glucose, behavioral traits (BT) after adjustment for age, HT, WT, glucose and uric acid and finally the apo E polymorphism after adjustment for age, HT, WT, glucose, uric acid, and BT. N/E = not explained. Traits that contribute significantty to LDL cholesterol variation at the 0.05 level of probability are represented as extended "pie pieces.' The corresponding percents appear in tables 2-5.
